Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study
Mehdi Farokhnia, Melanie L. Schwandt, M R Lee, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 4, pp. e1108-e1108
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Aryl Transfer Strategies Mediated by Photoinduced Electron Transfer
Anthony R. Allen, Efrey A. Noten, Corey R. J. Stephenson
Chemical Reviews (2021) Vol. 122, Iss. 2, pp. 2695-2751
Open Access | Times Cited: 164
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study
Mary R. Lee, Jenica D. Tapocik, Mwlod Ghareeb, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 2, pp. 461-475
Open Access | Times Cited: 115
Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial
Kirsten C. Morley, Andrew Baillie, I.S. Fraser, et al.
The British Journal of Psychiatry (2018) Vol. 212, Iss. 6, pp. 362-369
Open Access | Times Cited: 102
Pharmacotherapy of alcoholism – an update on approved and off-label medications
Michael Soyka, Christian A. Müller
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 12, pp. 1187-1199
Closed Access | Times Cited: 78
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
Renaud de Beaurepaire, Julia Sinclair, Mathis Heydtmann, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 70
Virtual reality: a powerful technology to provide novel insight into treatment mechanisms of addiction
Massimiliano Mazza, Kornelius Kammler-Sücker, Tagrid Leménager, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 36
The future of translational research on alcohol use disorder
Lara A. Ray, Erica N. Grodin, Lorenzo Leggio, et al.
Addiction Biology (2020) Vol. 26, Iss. 2
Open Access | Times Cited: 35
The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis
Roberta Agabio, David S. Baldwin, Hugo Amaro, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 296-313
Open Access | Times Cited: 27
The glucagon‐like peptide‐1 system is modulated by acute and chronic alcohol exposure: Findings from human laboratory experiments and a post‐mortem brain study
Mehdi Farokhnia, Brittney D. Browning, Madeline E. Crozier, et al.
Addiction Biology (2022) Vol. 27, Iss. 5
Closed Access | Times Cited: 19
A closer look at alcohol‐induced changes in the ghrelin system: novel insights from preclinical and clinical data
Sara L. Deschaine, Mehdi Farokhnia, Adriana Gregory‐Flores, et al.
Addiction Biology (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 25
Prospects for pharmacotherapies to treat alcohol use disorder
Mehdi Farokhnia, Brittney D. Browning, Lorenzo Leggio
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 4, pp. 255-265
Open Access | Times Cited: 28
Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies
Lorenzo Leggio, Daniel E. Falk, Megan L. Ryan, et al.
Handbook of experimental pharmacology (2019), pp. 443-462
Closed Access | Times Cited: 27
Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals
Warren Logge, Richard W. Morris, Andrew Baillie, et al.
Psychopharmacology (2019) Vol. 238, Iss. 5, pp. 1291-1302
Closed Access | Times Cited: 26
A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation
Mehdi Farokhnia, Sara L. Deschaine, Armin Sadighi, et al.
Molecular Psychiatry (2018) Vol. 26, Iss. 2, pp. 545-555
Open Access | Times Cited: 26
Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
Roberta Agabio, Lorenzo Leggio
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 24
A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects
Mototsugu Ito, Anna Spence, Mary Beth Blauwet, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 6, pp. 756-767
Closed Access | Times Cited: 13
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology
Lindsay R. Meredith, Elizabeth M. Burnette, Steven J. Nieto, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 9, pp. 1629-1645
Closed Access | Times Cited: 7
Advances in Pharmacotherapy Development: Human Clinical Studies
Raye Z. Litten, Daniel E. Falk, Megan L. Ryan, et al.
Handbook of experimental pharmacology (2017), pp. 579-613
Closed Access | Times Cited: 24
Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures
Claire Durant, Louise M. Paterson, Sam Turton, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 22
Effect of oral alcohol administration on plasma cytokine concentrations in heavy drinking individuals
Mary R. Lee, Kelly M. Abshire, Mehdi Farokhnia, et al.
Drug and Alcohol Dependence (2021) Vol. 225, pp. 108771-108771
Closed Access | Times Cited: 16
Neuroimaging and neuroendocrine insights into food cravings and appetite interventions in obesity
Jin Huang, Chen Wang, Hang-Bin Zhang, et al.
Deleted Journal (2023) Vol. 3
Open Access | Times Cited: 6
Microinjection of baclofen and CGP7930 into the ventral tegmental area suppresses alcohol self-administration in alcohol-preferring rats
Paola Maccioni, Irene Lorrai, A. Contini, et al.
Neuropharmacology (2017) Vol. 136, pp. 146-158
Closed Access | Times Cited: 21
Pharmacotherapeutic options for co-morbid depression and alcohol dependence
Thomas Hillemacher, Helge Frieling
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 5, pp. 547-569
Closed Access | Times Cited: 19
From gene networks to drugs: systems pharmacology approaches for AUD
Laura B. Ferguson, R. Adron Harris, Roy Dayne Mayfield
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1635-1662
Open Access | Times Cited: 17
A human laboratory study on the link between alcohol administration and circulating fibroblast growth factor 21 (FGF21) in individuals with alcohol use disorder
Mehdi Farokhnia, Tammy Wang, Tony Jourdan, et al.
Drug and Alcohol Dependence (2023) Vol. 245, pp. 109809-109809
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top